The global Integrase Inhibitors Market is estimated to be valued at US$ 29.34 Bn in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Integrase inhibitors are a class of antiretroviral drugs used to treat HIV/AIDS. They prevent HIV from integrating into a host's genetic...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian